Prevalence of systemic and ocular comorbidities in patients aged 18–50 years with retinal vein occlusion
International Ophthalmology · 29.10.2026 · 46 (1)
DOI: 10.1007/s10792-026-04312-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Ophthalmology, online erschienen am 29.10.2026. Verfasst von Charles Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL, 33136, USA. c…. Hauptthemen laut MEDLINE: Hypertension, Obesity, Retinal Vein Occlusion. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
Retinal vein occlusion (RVO) is a well-established cause of vision loss in older adults. However, the prevalence and distribution of documented systemic comorbidities in younger adults are not well characterized.
Methods
This retrospective cohort study utilized the TriNetX US Collaborative Network to identify younger adults (aged 18–50 years) with retinal vein occlusion (RVO), including both branch (BRVO) and central (CRVO) subtypes. The prevalence of predefined systemic comorbidities was evaluated during the period preceding and within 90 days following the diagnosis of RVO to characterize their frequency and distribution among young patients.
Results
A total of 5,257 younger adults with RVO were included. Before RVO diagnosis, 66.4% of patients had at least one documented risk factor, most commonly hypertension (25%), obesity (17.4%), and type 2 diabetes mellitus (13.3%). Primary thrombophilia (2.2%) and hematologic malignancy (1.6%) were less frequently documented. Within 90 days following RVO diagnosis, 12.3% of patients received at least one newly coded risk-factor diagnosis, most commonly hypertension (4.5%), obesity (2.3%), and hyperlipidemia (1.9%). Among patients without any previously documented risk factors, 3.7% had at least one risk factor newly documented during this period.
Conclusions
Among young adults with RVO, common vascular comorbidities were documented more frequently than hypercoagulable or vasculitic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL, 33136, USA. cfhzhang@gmail.com.
- Department of Ophthalmology, Ross Eye Institute, SUNY Buffalo, Buffalo, NY, USA. cfhzhang@gmail.com.
- Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL, 33136, USA.
- Department of Ophthalmology, Ross Eye Institute, SUNY Buffalo, Buffalo, NY, USA.
- Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
ORCID-Profile: Charles Zhang
Zitieren
APA
Zhang, C., Allaf, A. M., Ersan, S., Sosa-Lockward, J., Williams, B. K., & Berrocal, A. M. (2026). Prevalence of systemic and ocular comorbidities in patients aged 18–50 years with retinal vein occlusion. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04312-3
Vancouver
Zhang C, Allaf AM, Ersan S, Sosa-Lockward J, Williams BK, Berrocal AM. Prevalence of systemic and ocular comorbidities in patients aged 18–50 years with retinal vein occlusion. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04312-3
BibTeX
@article{Zhang2026,
author = {Zhang, Charles and Allaf, Abdulrahman Mamoon and Ersan, Sinan and Sosa-Lockward, Joaquin and Williams, Basil K and Berrocal, Audina M},
title = {Prevalence of systemic and ocular comorbidities in patients aged 18–50 years with retinal vein occlusion},
journal = {International Ophthalmology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10792-026-04312-3}
}
EUVIMED